2) Gandara DR, Roila F, Warr D, et al: Concensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration. Support Care Cancer 6: 237-243, 1998.
3) NCI Common Toxicity Criteria. Bethesda, MD, National Cancer Institute, Division of Cancer Treatment, 1988.
4) Murray N, Shah A, Osoba D, et al: Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. J Clin Oncol 9: 1632-1638, 1991.
5) Kris MG, Gralla RJ, Tyson LB, et al: Controlling delayed vomiting; double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7: 108-114, 1989.